FDA Inspection 898075 — ThromboGenics, Inc.

ThromboGenics, Inc. — FEI 3010447101

The FDA completed an inspection of ThromboGenics, Inc. on Sep 19, 2014 in Iselin, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 19, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Iselin, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.